Literature DB >> 23664668

Toward clinical application of the Keap1-Nrf2 pathway.

Takafumi Suzuki1, Hozumi Motohashi, Masayuki Yamamoto.   

Abstract

The Keap1-Nrf2 pathway plays a crucial role in determining the sensitivity of cells to chemical and/or oxidative insults by regulating the basal and inducible expression of detoxification and antioxidant enzymes, ABC transporters, and other stress response enzymes and/or proteins. Increasing attention has been focused on the roles that the Keap1-Nrf2 pathway plays in the protection of our body against drug toxicity and stress-induced diseases. Simultaneously, Nrf2 has been recognized to promote oncogenesis and resistance to chemotherapeutic drugs. Cancer cells hijack Nrf2 activity to support their malignant growth and thus Nrf2 has emerged as a therapeutic target. Translational studies of the Keap1-Nrf2 system, from mechanistic understanding to clinical applications, are now important to improve human health.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23664668     DOI: 10.1016/j.tips.2013.04.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  246 in total

1.  Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.

Authors:  Yasuhiro Nakagami; Kayoko Masuda; Emiko Hatano; Tatsuya Inoue; Takuya Matsuyama; Mayumi Iizuka; Yasunori Ono; Takashi Ohnuki; Yoko Murakami; Masaru Iwasaki; Kazuhiro Yoshida; Yuji Kasuya; Satoshi Komoriya
Journal:  Br J Pharmacol       Date:  2015-01-12       Impact factor: 8.739

2.  Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways.

Authors:  Ruo-ming Wu; Yan-yan Sun; Ting-ting Zhou; Zhi-yuan Zhu; Jing-jing Zhuang; Xuan Tang; Jing Chen; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

3.  IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model.

Authors:  H Kitamura; Y Onodera; S Murakami; T Suzuki; H Motohashi
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

4.  Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.

Authors:  Tatsuro Iso; Takafumi Suzuki; Liam Baird; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

Review 5.  Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?

Authors:  Sih Min Tan; Judy B de Haan
Journal:  Redox Rep       Date:  2014-02-21       Impact factor: 4.412

6.  Polar Recognition Group Study of Keap1-Nrf2 Protein-Protein Interaction Inhibitors.

Authors:  Meng-Chen Lu; Shi-Jie Tan; Jian-Ai Ji; Zhi-Yun Chen; Zhen-Wei Yuan; Qi-Dong You; Zheng-Yu Jiang
Journal:  ACS Med Chem Lett       Date:  2016-07-05       Impact factor: 4.345

7.  The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11.

Authors:  Tong Liu; Le Jiang; Omid Tavana; Wei Gu
Journal:  Cancer Res       Date:  2019-02-01       Impact factor: 12.701

8.  Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels.

Authors:  Hui-Xian Zhang; Yang Chen; Rong Xu; Qi-Yang He
Journal:  Acta Pharmacol Sin       Date:  2018-05-10       Impact factor: 6.150

9.  NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.

Authors:  Jung-Hyun Kim; Rajesh K Thimmulappa; Vineet Kumar; Wanchang Cui; Sarvesh Kumar; Ponvijay Kombairaju; Hao Zhang; Joseph Margolick; William Matsui; Thomas Macvittie; Sanjay V Malhotra; Shyam Biswal
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

10.  Overactivation of the nuclear factor (erythroid-derived 2)-like 2-antioxidant response element pathway in hepatocytes decreases hepatic ischemia/reperfusion injury in mice.

Authors:  Lung-Yi Lee; Calvin Harberg; Kristina A Matkowskyj; Shelly Cook; Drew Roenneburg; Sabine Werner; Jeffrey Johnson; David P Foley
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.